Blood Glucose Control

Ricardo, a 35-year-old man, newly diagnosed with type 1 diabetes, was hospitalized for diabetic ketoacidosis (DKA).  Once he was stabilized, he wanted to go home. He refused to learn how to self-administer insulin. However, he was told he would not be discharged until he self-administered insulin, at least one time....

A study in California highlights the importance of addressing cultural and structural barriers in implementing shared medical appointments. 

With stay-at-home orders, daily routines for many diabetes patients have been disrupted, creating concerns over the possible consequences of added stress, isolation, and elevated blood sugars.

Imeglimin, a new, first-in-class blood-glucose-lowering agent, proves to be safe and efficient as monotherapy and adjunctive therapy to lower A1C in patients with type 2 diabetes. 

Study shows that visit-to-visit HbA1C variability can have significant effects on the prognosis for patients living with diabetes.

John, a gentleman in his 70's who has diabetes, always visited my group after he exercised. I noticed he always had something (hard candy) in his mouth and he seemed tired. I asked him why he was doing this candy thing. He said, "After exercise I like to refresh my breath, and want to make sure I prevent a low blood sugar...."

The new HbA1c variability score (HVS) allows HbA1c variability to be more easily and consistently studied.

The familiarity of using hemoglobin A1C value to guide control in patients with type 2 diabetes is known, but how do these longitudinal values relate to cardiovascular outcomes?

Minimization of secondary diabetic complications from early glycemic control in type 2 diabetes patients. 

Data focuses on veterans who have poorly controlled diabetes, and whether the intervention of self-care management skills works as compared to using traditional means of education.